| Group F (n = 39) | Group O (n = 36) | Group B (n = 37) |
---|---|---|---|
Age (y) | 52.5 ± 6.6 | 51.4 ± 6.7 | 51.4 ± 6.9 |
Height (cm) | 159.7 ± 4.6 | 159.1 ± 4.0 | 160.2 ± 4.2 |
Weight (kg) | 60 (55–72) | 60 (60–68) | 60 (56–74) |
BMI (kg/m2) | 24.7 (22.1–25.8) | 24.9 (23.4–26.5) | 23.4 (22–25) |
ASA status | Â | Â | Â |
I [n (%)] | 4 (10.3) | 3 (8.3) | 2 (5.4) |
II [n (%)] | 35 (89.7) | 33 (91.7) | 35 (94.6) |
Diagnosis | Â | Â | Â |
Cancer [n (%)] | 18 (46.2) | 15 (41.7) | 18 (48.6) |
CIN [n (%)] | 12 (30.8) | 14 (38.9) | 9 (24.4) |
Uterine fibroids [n (%)] | 6 (15.3) | 3 (8.3) | 7 (18.9) |
Adenomyosis [n (%)] | 3 (7.7) | 4 (11.1) | 3 (8.1) |
Duration of surgery (min) | 132 (100–193) | 125 (90–159) | 115 (90–140) |
Duration of anesthesia (min) | 162 (120–235) | 153(121–185) | 140 (112–165) |
Consumption of fentanyl (mg) | 0.55 (0.50–0.65) | 0.60 (0.50–0.60) | 0.55 (0.50–0.60) |
Total fluid (mL) | 2100 (1600–2675) | 2100 (1975–2500) | 2000 (1600–2600) |
Total loss (mL) | 300 (200–507) | 250 (150–400) | 250 (150–388) |
Leukocyte count (*109/L) | 5.7 (4.7–7.3) | 5.3 (4.7–6.6) | 5.2 (4.4–6) |
Percentage of neutrophils (%) | 56.3 (51.6–64.2) | 56.3 (51.4–64.5) | 56.5 (52.3–60.1) |
Potassium (mmol/L) | 3.8 (3.5–4.0) | 3.8 (3.5–4.0) | 3.8 (3.6–4.0) |